Grant: Foundation Grant
Research Institute of the McGill University Health Centre
$2,270,367.00
Human Fungal Infections - Targeting host-pathogen interactions to develop novel antifungal therapies
FY 2017-18
Summary
Fungal infections are common and devastating in patients whose immune systems do not work properly or those with long-term lung disease. Our research program seeks to understand at a molecular level how molds and other fungi can cause human disease. We have identified two types of sugars made by fungi such as the mold Aspergillus that allow them to attach to human tissues and invade our lungs. We have developed new therapies that target these sugars in order to develop new therapies to treat or prevent these infections. These therapies include proteins that can be used to break down these sugars during infection, and vaccines that boost the response of our immune system against fungi. These strategies have already shown promise in animal studies. In the coming years we will refine and optimize these therapies and continue our discovery research to identify new sugar molecules that fungi use to cause human disease. Identifying these new sugars will provide us with new targets for our antifungal development pipeline. These studies will both improve our understanding of how fungi cause human disease, and provide us with new weapons in the fight against these devastating infections.
Department
Program
Foundation Grant
Location
Quebec, Canada
Type
Grant
Source
CIHR Funding Decisions Database
As published
Id
368096
Name
Sheppard Donald C
Region
Québec
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Infection and Immunity
Theme2
Biomedical
Prcname2
Foundation Grant
Projecttitle
Human Fungal Infections - Targeting host-pathogen interactions to develop novel antifungal therapies
Programtype2
Operating Grants
Orgnameinp2
Research Institute of the McGill University Health Centre
Cihramount2
$2,270,367
Cihrequipment2
$0
Programname2
Foundation Grant
Keyworddelim
Antifungals; Aspergillus; Biofilm; Host Immunity; Host-Pathogen Interactions; Medical Mycology; Pseudomonas; Vaccines
Abstract
Fungal infections are common and devastating in patients whose immune systems do not work properly or those with long-term lung disease. Our research program seeks to understand at a molecular level how molds and other fungi can cause human disease. We have identified two types of sugars made by fungi such as the mold Aspergillus that allow them to attach to human tissues and invade our lungs. We have developed new therapies that target these sugars in order to develop new therapies to treat or prevent these infections. These therapies include proteins that can be used to break down these sugars during infection, and vaccines that boost the response of our immune system against fungi. These strategies have already shown promise in animal studies. In the coming years we will refine and optimize these therapies and continue our discovery research to identify new sugar molecules that fungi use to cause human disease. Identifying these new sugars will provide us with new targets for our antifungal development pipeline. These studies will both improve our understanding of how fungi cause human disease, and provide us with new weapons in the fight against these devastating infections.
Competitiondate
201709
Approvedterm2
7 yrs 0 mth
Pinamesdelim
Sheppard, Donald C
Approvedterm
7 ans 0 mois
Cihrcontribution2
~ $2,270,367~ $0~